Stock Information
Vertex Pharmaceuticals Inc (VRTX)
Ticker Symbol: VRTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $121,999.92 mil
Piotroski score: 6
PE Ratio: 27.9272
EPS (TTM): 16.8667
Revenue (TTM): $47.67 M
Dividend Yield: N/A%
ROE: 23.93%
Latest News
-
Vortex Energy Corp. Announces Marketing Program
Fri, Jul 24, 2026 9:00 PM
-
Is Arrowhead Pharmaceuticals Stock A Smart Buy After Its Transition To A Commercial Company?
Thu, Jul 23, 2026 3:00 PM
-
3 Healthcare Stocks with Competitive Advantages
Thu, Jul 23, 2026 10:22 AM
-
Vertex Pharmaceuticals (VRTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Wed, Jul 22, 2026 9:50 PM
-
Vertex was sole bidder in high-premium Crinetics acquisition
Wed, Jul 22, 2026 4:48 PM
-
These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why
Tue, Jul 21, 2026 3:52 PM
-
A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up
Tue, Jul 21, 2026 1:00 PM
-
Biotech IPO Gains Crush AI Listings With Standout 55% Return
Tue, Jul 21, 2026 12:35 PM
-
Vertex Pharmaceuticals (NASDAQ:VRTX): An Affordable Growth Stock Balancing Strong Fundamentals With Reasonable Valuation
Tue, Jul 21, 2026 12:20 PM
-
Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today
Mon, Jul 20, 2026 10:00 PM
Key Financials
Financial data not available
